01562nas a2200373   4500000000100000008004100001260001300042653001200055653002000067653001600087653001100103653003000114653001100144653002400155653002200179653002100201653002300222653001200245653001600257653000900273653002000282100001100302700001300313700001700326700001200343700001200355700001300367700001400380245011500394300001000509490000700519520064800526022001401174       1986                            d  c1986 Mar10aAbdomen10aChronic Disease10aClofazimine10aFemale10aGastrointestinal Motility10aHumans10aIntestinal Diseases10aIntestinal Mucosa10aIntestine, Small10aLeprostatic Agents10aleprosy10aMiddle Aged10aPain10aUltrasonography1 aDavy C1 aRiveau E1 aBousquet J C1 aCuret P1 aVayre P1 aCortez A1 aGrellet J00a[Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].  a213-80 v673 a<p>This new case of enteropathy due to Clofazimine provided demonstration of the diagnostic value of small bowel follow-through examination in this complication. Various small intestine anomalies have been reported: ileal or partial jejunal lesions; variations in caliber; loss of physiologic folds; irregularly outlined surface and border lacunae and persistence of suppleness of pathologic loops. Knowledge of these anomalies should avoid exploratory laparotomy, Clofazimine-induced enteropathy regressing after discontinuation of treatment. Repeat small bowel follow up examinations can be performed to review course of this regression.</p>  a0221-0363